GB2125041B - Ergot alkaloids - Google Patents

Ergot alkaloids

Info

Publication number
GB2125041B
GB2125041B GB08321222A GB8321222A GB2125041B GB 2125041 B GB2125041 B GB 2125041B GB 08321222 A GB08321222 A GB 08321222A GB 8321222 A GB8321222 A GB 8321222A GB 2125041 B GB2125041 B GB 2125041B
Authority
GB
United Kingdom
Prior art keywords
ergot alkaloids
ergot
alkaloids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08321222A
Other versions
GB8321222D0 (en
GB2125041A (en
Inventor
Peter Gull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8321222D0 publication Critical patent/GB8321222D0/en
Publication of GB2125041A publication Critical patent/GB2125041A/en
Application granted granted Critical
Publication of GB2125041B publication Critical patent/GB2125041B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GB08321222A 1982-08-09 1983-08-05 Ergot alkaloids Expired GB2125041B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (en) 1982-08-09 1982-08-09 ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.

Publications (3)

Publication Number Publication Date
GB8321222D0 GB8321222D0 (en) 1983-09-07
GB2125041A GB2125041A (en) 1984-02-29
GB2125041B true GB2125041B (en) 1986-04-23

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08321222A Expired GB2125041B (en) 1982-08-09 1983-08-05 Ergot alkaloids

Country Status (23)

Country Link
JP (1) JPS5948480A (en)
AT (1) AT383125B (en)
AU (1) AU563736B2 (en)
BE (1) BE897473A (en)
CA (1) CA1215972A (en)
CH (1) CH649998A5 (en)
DE (1) DE3327705A1 (en)
DK (1) DK361983A (en)
ES (1) ES524815A0 (en)
FI (1) FI73679C (en)
FR (1) FR2531433B1 (en)
GB (1) GB2125041B (en)
GR (1) GR78923B (en)
HU (1) HU187600B (en)
IL (1) IL69450A (en)
IT (1) IT1168961B (en)
MY (1) MY8700166A (en)
NL (1) NL8302776A (en)
NZ (1) NZ205181A (en)
PH (1) PH20385A (en)
PT (1) PT77168B (en)
SE (1) SE8304315L (en)
ZA (1) ZA835850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (en) * 1989-04-21 1990-10-25 Schering Ag 8 (BETA) SUBSTITUTED ERGOLINE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
ES8502992A1 (en) 1985-02-01
MY8700166A (en) 1987-12-31
DK361983A (en) 1984-02-10
DE3327705A1 (en) 1984-02-09
NZ205181A (en) 1986-07-11
ZA835850B (en) 1985-03-27
AT383125B (en) 1987-05-25
IL69450A0 (en) 1983-11-30
FI832789A (en) 1984-02-10
NL8302776A (en) 1984-03-01
IT1168961B (en) 1987-05-20
FR2531433B1 (en) 1985-10-18
BE897473A (en) 1984-02-06
CH649998A5 (en) 1985-06-28
FR2531433A1 (en) 1984-02-10
AU1767283A (en) 1984-02-16
ATA286383A (en) 1986-10-15
AU563736B2 (en) 1987-07-23
SE8304315L (en) 1984-02-10
JPS5948480A (en) 1984-03-19
IT8322490A0 (en) 1983-08-09
SE8304315D0 (en) 1983-08-08
GR78923B (en) 1984-10-02
PT77168A (en) 1983-09-01
FI73679B (en) 1987-07-31
IL69450A (en) 1986-10-31
FI73679C (en) 1987-11-09
GB8321222D0 (en) 1983-09-07
HU187600B (en) 1986-01-28
ES524815A0 (en) 1985-02-01
GB2125041A (en) 1984-02-29
DK361983D0 (en) 1983-08-08
CA1215972A (en) 1986-12-30
FI832789A0 (en) 1983-08-02
PT77168B (en) 1986-03-27
PH20385A (en) 1986-12-08

Similar Documents

Publication Publication Date Title
GB8311973D0 (en) Quinoline derivatives
DE3377796D1 (en) Quinoline derivatives
ZA833008B (en) Ergoline derivatives
GB2125041B (en) Ergot alkaloids
AU553514B2 (en) Vinca alkaloids
GB8303475D0 (en) Ergot alkaloids
GB2093452B (en) Ergoline derivatives
PT72785B (en) Ergoline derivatives
GB2115811B (en) Ergot alkaloids
GB2092570B (en) Ergot alkaloids
ZA812103B (en) Ergoline derivatives
NZ189422A (en) Ergot peptide alkaloids
ZA83955B (en) Ergot alkaloids
GB2094798B (en) Ergot alkaloids
PH20160A (en) Ergoline derivatives
JPS57159783A (en) Manufacture of ergot alkaloids
GB2131674B (en) Ashtray
IE802091L (en) Ergot peptide alkaloids
GB2135307B (en) Ergot derivatives
KR840000329Y1 (en) Ashtray
KR860000957Y1 (en) Ashtray
ZA841150B (en) Ergot derivatives
GB8312447D0 (en) Ergot derivatives
KR830001175Y1 (en) Ash-tray
IE822659L (en) Morphinane derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee